Switch to:
Also traded in: France, Germany, Italy, Mexico, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.22
ESLOY's Cash-to-Debt is ranked lower than
87% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. ESLOY: 0.22 )
Ranked among companies with meaningful Cash-to-Debt only.
ESLOY' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.21  Med: 0.89 Max: 2.52
Current: 0.22
0.21
2.52
Equity-to-Asset 0.51
ESLOY's Equity-to-Asset is ranked lower than
63% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. ESLOY: 0.51 )
Ranked among companies with meaningful Equity-to-Asset only.
ESLOY' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.46  Med: 0.56 Max: 0.65
Current: 0.51
0.46
0.65
Interest Coverage 17.32
ESLOY's Interest Coverage is ranked lower than
63% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 45.06 vs. ESLOY: 17.32 )
Ranked among companies with meaningful Interest Coverage only.
ESLOY' s Interest Coverage Range Over the Past 10 Years
Min: 6.87  Med: 23.56 Max: N/A
Current: 17.32
Piotroski F-Score: 4
Altman Z-Score: 3.83
Beneish M-Score: -2.53
WACC vs ROIC
5.09%
10.81%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 17.29
ESLOY's Operating Margin % is ranked higher than
82% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.86 vs. ESLOY: 17.29 )
Ranked among companies with meaningful Operating Margin % only.
ESLOY' s Operating Margin % Range Over the Past 10 Years
Min: 15.89  Med: 16.79 Max: 21.55
Current: 17.29
15.89
21.55
Net Margin % 11.43
ESLOY's Net Margin % is ranked higher than
76% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.79 vs. ESLOY: 11.43 )
Ranked among companies with meaningful Net Margin % only.
ESLOY' s Net Margin % Range Over the Past 10 Years
Min: 11.27  Med: 12.1 Max: 16.38
Current: 11.43
11.27
16.38
ROE % 13.26
ESLOY's ROE % is ranked higher than
77% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.30 vs. ESLOY: 13.26 )
Ranked among companies with meaningful ROE % only.
ESLOY' s ROE % Range Over the Past 10 Years
Min: 13.12  Med: 16.09 Max: 21.43
Current: 13.26
13.12
21.43
ROA % 6.52
ESLOY's ROA % is ranked higher than
72% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.23 vs. ESLOY: 6.52 )
Ranked among companies with meaningful ROA % only.
ESLOY' s ROA % Range Over the Past 10 Years
Min: 6.47  Med: 9.31 Max: 11.16
Current: 6.52
6.47
11.16
ROC (Joel Greenblatt) % 68.43
ESLOY's ROC (Joel Greenblatt) % is ranked higher than
90% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.88 vs. ESLOY: 68.43 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ESLOY' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 49.72  Med: 59.78 Max: 72.81
Current: 68.43
49.72
72.81
3-Year Revenue Growth Rate 10.90
ESLOY's 3-Year Revenue Growth Rate is ranked higher than
77% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. ESLOY: 10.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ESLOY' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -0.5  Med: 9.5 Max: 15.1
Current: 10.9
-0.5
15.1
3-Year EBITDA Growth Rate 12.50
ESLOY's 3-Year EBITDA Growth Rate is ranked higher than
69% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.80 vs. ESLOY: 12.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ESLOY' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -2.2  Med: 9.4 Max: 23.8
Current: 12.5
-2.2
23.8
3-Year EPS without NRI Growth Rate 10.10
ESLOY's 3-Year EPS without NRI Growth Rate is ranked higher than
60% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. ESLOY: 10.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ESLOY' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 6.6  Med: 10.1 Max: 21.5
Current: 10.1
6.6
21.5
GuruFocus has detected 6 Warning Signs with Essilor International SA $ESLOY.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ESLOY's 30-Y Financials

Financials (Next Earnings Date: 2017-10-21 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with ESLOY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339115 
Compare:NYSE:BAX, NAS:ILMN, NYSE:BCR, NYSE:BDX, OTCPK:CLPBY, NYSE:MTD, NAS:XRAY, OTCPK:TRUMY, NYSE:WAT, OTCPK:OCPNY, NAS:HOLX, NYSE:COO, NYSE:RMD, OTCPK:SAUHY, NYSE:WST, NYSE:STE, OTCPK:GNGBF, NYSE:HRC, NAS:ICUI, NYSE:CMD » details
Traded in other countries:EI.France, ESL.Germany, EI.Italy, EIN.Mexico, EI.Switzerland, 0OMK.UK,
Headquarter Location:France
Essilor International SA designs, manufactures, purchases, sells and trades all eyewear and optical products. It also manufactures, purchases and sales frames, sunglasses, protective lenses and other protective equipment.

Essilor, with headquarters in France, is the world's largest manufacturer of optical lenses for vision correction. The company operates 14 manufacturing plants, 12 distribution centers, 3 research centers, and more than 300 prescription laboratories. Essilor produces more than 200 million lenses representing more than 500,000 stock-keeping units. Through Satisloh and FGX International, Essilor also sells lens-manufacturing equipment, nonprescription sunglasses, and reading glasses.

Ratios

vs
industry
vs
history
PE Ratio 32.03
ESLOY's PE Ratio is ranked higher than
53% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.48 vs. ESLOY: 32.03 )
Ranked among companies with meaningful PE Ratio only.
ESLOY' s PE Ratio Range Over the Past 10 Years
Min: 14.01  Med: 26.27 Max: 34.9
Current: 32.03
14.01
34.9
Forward PE Ratio 27.70
ESLOY's Forward PE Ratio is ranked lower than
60% of the 78 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.42 vs. ESLOY: 27.70 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 32.03
ESLOY's PE Ratio without NRI is ranked higher than
53% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.38 vs. ESLOY: 32.03 )
Ranked among companies with meaningful PE Ratio without NRI only.
ESLOY' s PE Ratio without NRI Range Over the Past 10 Years
Min: 14.01  Med: 26.27 Max: 34.9
Current: 32.03
14.01
34.9
Price-to-Owner-Earnings 20.30
ESLOY's Price-to-Owner-Earnings is ranked higher than
76% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.93 vs. ESLOY: 20.30 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
ESLOY' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.17  Med: 20.22 Max: 32.95
Current: 20.3
12.17
32.95
PB Ratio 3.82
ESLOY's PB Ratio is ranked lower than
52% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.56 vs. ESLOY: 3.82 )
Ranked among companies with meaningful PB Ratio only.
ESLOY' s PB Ratio Range Over the Past 10 Years
Min: 2.36  Med: 4.08 Max: 5.32
Current: 3.82
2.36
5.32
PS Ratio 3.67
ESLOY's PS Ratio is ranked lower than
53% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.01 vs. ESLOY: 3.67 )
Ranked among companies with meaningful PS Ratio only.
ESLOY' s PS Ratio Range Over the Past 10 Years
Min: 1.75  Med: 3.25 Max: 4.67
Current: 3.67
1.75
4.67
Price-to-Free-Cash-Flow 28.95
ESLOY's Price-to-Free-Cash-Flow is ranked higher than
52% of the 73 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.88 vs. ESLOY: 28.95 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ESLOY' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 17.98  Med: 28.23 Max: 40.56
Current: 28.95
17.98
40.56
Price-to-Operating-Cash-Flow 21.81
ESLOY's Price-to-Operating-Cash-Flow is ranked lower than
53% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.90 vs. ESLOY: 21.81 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ESLOY' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.41  Med: 19.57 Max: 25.68
Current: 21.81
10.41
25.68
EV-to-EBIT 22.75
ESLOY's EV-to-EBIT is ranked higher than
66% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.30 vs. ESLOY: 22.75 )
Ranked among companies with meaningful EV-to-EBIT only.
ESLOY' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.9  Med: 19.3 Max: 24.2
Current: 22.75
8.9
24.2
EV-to-EBITDA 17.63
ESLOY's EV-to-EBITDA is ranked higher than
64% of the 203 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.15 vs. ESLOY: 17.63 )
Ranked among companies with meaningful EV-to-EBITDA only.
ESLOY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.1  Med: 15 Max: 18.8
Current: 17.63
7.1
18.8
PEG Ratio 2.41
ESLOY's PEG Ratio is ranked higher than
57% of the 58 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.65 vs. ESLOY: 2.41 )
Ranked among companies with meaningful PEG Ratio only.
ESLOY' s PEG Ratio Range Over the Past 10 Years
Min: 1.29  Med: 2.7 Max: 13.07
Current: 2.41
1.29
13.07
Shiller PE Ratio 41.08
ESLOY's Shiller PE Ratio is ranked higher than
56% of the 45 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 43.41 vs. ESLOY: 41.08 )
Ranked among companies with meaningful Shiller PE Ratio only.
ESLOY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 29.82  Med: 40.87 Max: 50.97
Current: 41.08
29.82
50.97
Current Ratio 0.94
ESLOY's Current Ratio is ranked lower than
92% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. ESLOY: 0.94 )
Ranked among companies with meaningful Current Ratio only.
ESLOY' s Current Ratio Range Over the Past 10 Years
Min: 0.94  Med: 1.76 Max: 2.57
Current: 0.94
0.94
2.57
Quick Ratio 0.64
ESLOY's Quick Ratio is ranked lower than
94% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. ESLOY: 0.64 )
Ranked among companies with meaningful Quick Ratio only.
ESLOY' s Quick Ratio Range Over the Past 10 Years
Min: 0.64  Med: 1.21 Max: 2.03
Current: 0.64
0.64
2.03
Days Inventory 138.92
ESLOY's Days Inventory is ranked lower than
60% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.79 vs. ESLOY: 138.92 )
Ranked among companies with meaningful Days Inventory only.
ESLOY' s Days Inventory Range Over the Past 10 Years
Min: 113.1  Med: 133.86 Max: 144.99
Current: 138.92
113.1
144.99

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.18
ESLOY's Dividend Yield % is ranked lower than
59% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. ESLOY: 1.18 )
Ranked among companies with meaningful Dividend Yield % only.
ESLOY' s Dividend Yield % Range Over the Past 10 Years
Min: 0.76  Med: 1.25 Max: 7.37
Current: 1.18
0.76
7.37
Dividend Payout Ratio 0.30
ESLOY's Dividend Payout Ratio is ranked higher than
52% of the 85 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.30 vs. ESLOY: 0.30 )
Ranked among companies with meaningful Dividend Payout Ratio only.
ESLOY' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.22  Med: 0.32 Max: 1.07
Current: 0.3
0.22
1.07
3-Year Dividend Growth Rate 8.00
ESLOY's 3-Year Dividend Growth Rate is ranked lower than
58% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.60 vs. ESLOY: 8.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
ESLOY' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -24.6  Med: 8 Max: 45.5
Current: 8
-24.6
45.5
Forward Dividend Yield % 1.18
ESLOY's Forward Dividend Yield % is ranked higher than
52% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.35 vs. ESLOY: 1.18 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.59
ESLOY's 5-Year Yield-on-Cost % is ranked lower than
61% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. ESLOY: 1.59 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
ESLOY' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.02  Med: 1.68 Max: 9.91
Current: 1.59
1.02
9.91
3-Year Average Share Buyback Ratio -0.70
ESLOY's 3-Year Average Share Buyback Ratio is ranked higher than
62% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.20 vs. ESLOY: -0.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ESLOY' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.2  Med: -0.4 Max: 0.4
Current: -0.7
-1.2
0.4

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.72
ESLOY's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
66% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.03 vs. ESLOY: 1.72 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ESLOY' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.42  Med: 1.65 Max: 2.61
Current: 1.72
1.42
2.61
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.14
ESLOY's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
52% of the 23 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.04 vs. ESLOY: 2.14 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.13
ESLOY's Price-to-Median-PS-Value is ranked higher than
53% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.14 vs. ESLOY: 1.13 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ESLOY' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.25  Med: 0.91 Max: 1.14
Current: 1.13
0.25
1.14
Price-to-Peter-Lynch-Fair-Value 2.42
ESLOY's Price-to-Peter-Lynch-Fair-Value is ranked lower than
57% of the 42 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.21 vs. ESLOY: 2.42 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
ESLOY' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 1.05  Med: 2.15 Max: 3.27
Current: 2.42
1.05
3.27
Earnings Yield (Greenblatt) % 4.39
ESLOY's Earnings Yield (Greenblatt) % is ranked higher than
75% of the 267 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.18 vs. ESLOY: 4.39 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ESLOY' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.1  Med: 5.2 Max: 11.2
Current: 4.39
4.1
11.2
Forward Rate of Return (Yacktman) % 16.04
ESLOY's Forward Rate of Return (Yacktman) % is ranked higher than
72% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. ESLOY: 16.04 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ESLOY' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 4.3  Med: 12.1 Max: 18.6
Current: 16.04
4.3
18.6

More Statistics

Revenue (TTM) (Mil) $7,752
EPS (TTM) $ 2.02
Beta0.78
Short Percentage of Float0.00%
52-Week Range $50.35 - 67.99
Shares Outstanding (Mil)433.02

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 8,417 8,987 9,675
EPS ($) 2.35 2.60 2.91
EPS without NRI ($) 2.35 2.60 2.91
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.12%
Dividends per Share ($) 0.64 0.71 0.95
» More Articles for ESLOY

Headlines

Articles On GuruFocus.com
Invesco European Growth Fund 4th Quarter Performance Commentary Feb 23 2017 
Chris Davis Comments on Essilor International SA Sep 09 2014 
Chris Davis International Fund Semi-Annual Portfolio Review Sep 08 2014 

More From Other Websites
Essilor International (CG d'Optique) S.A. -- Moody's: Essilor's A2 rating and positive outlook... Apr 11 2017
Europe Benchmarks Close Higher With Records Mar 17 2017
Essilor International SA :ESLOY-US: Earnings Analysis: For the six months ended December 31, 2016 :... Mar 06 2017
Essilor Announces Finalists in See Change Challenge to Improve Access to Vision Care in Underserved... Mar 02 2017
Essilor International SA :ESLOY-US: Earnings Analysis: 2016 By the Numbers : February 21, 2017 Feb 21 2017
Essilor Says $49 Billion Luxottica Deal On Track as it Posts Solid Q4 Results Feb 17 2017
The Biggest Risks Behind a Luxottica-Essilor Merger Feb 02 2017
Why Luxottica Group and Essilor International Pair So Well Together Feb 01 2017
The Luxottica Essilor Mega-Merger: Company Overviews Jan 31 2017
Everything You Need to Know About Luxottica and Essilor's $50 Billion Merger Jan 27 2017
Does Luxottica Now Have A Monopoly On The Eyeglass Space? Jan 17 2017
Essilor International (CG d'Optique) S.A. -- Moody's affirms Essilor's A2 rating; outlook changed to... Jan 17 2017
Eyewear giant to emerge from tie-up of Luxottica, Essilor Jan 16 2017
After $50 billion Eyewear Deal, Luxottica Will Now Dominate People's Faces Globally Jan 16 2017
European Stocks Fall as Automakers, Banks Lead Declines Jan 16 2017
Essilor Stock Falls Sharply After Revenue Guidance Cut Nov 22 2016
Essilor International SA :ESLOY-US: Earnings Analysis: For the six months ended June 30, 2016 :... Aug 09 2016
Essilor named No. 5 in Newsweek's 2016 Green Rankings Jun 13 2016
Essilor International SA Earnings Analysis: 2015 By the Numbers Feb 22 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat